[ PRINT ]
Abramson Family Cancer Research Institute
"Confronting Cancer Through Art" is an exhibition by people whose lives have been touched by cancer.
This week's artwork was donated by a pediatric cancer patient who received treatment for cancer at The Children's Hospital of Philadelphia. |
Ductal Carcinoma in situ Of The Breast: The Breast With Carcinoma in situ
Authors: Margaret M. Barnes, M.D Affiliations: Department of Radiation Oncology, University of Pennsylvania Cancer Center Posting Date - March 7, 1997 ![]() Last Revision Date: Sunday, 14-Feb-1999 13:54:25 EST
Copyright © 1994-1999, The Trustees of the University of Pennsylvania
Lobular Carcinoma in situ (LCIS): When the normal lining cells of the lobules begin to grow out of control, the cells will heap up, and under the microscope are seen one or more lobules filled with these abnormal cells:
Ductal Carcinoma in situ (DCIS): This in situ tumor develops when the lining cells of the breast ducts begin to grow out of control with cells that are pre-malignant. These in situ cancer cells, however, stay inside the basement membrane sleeve of the duct; the tumor does not invade through the basement membrane. Another name for DCIS is intraductal carcinoma of the breast because the carcinoma stays "within" the ducts.
The individual cancer cells that are growing in DCIS are believed to be true cancer cells. If untreated, or if treated inappropriately, these cancer cells may eventually develop ability to invade through the basement membrane and become an invasive (or infiltrating) carcinoma with the ultimate ability to spread through the body.
|
![]() |
GENERAL DISCLAIMER OncoLink is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through OncoLink should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, you should consult your health care provider. |
For further information, consult the Editors at: editors@oncolink.upenn.edu |